Sign up
Log in
12 Health Care Stocks Moving In Tuesday's After-Market Session
Share
Listen to the news

Gainers

  • Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday's after-market session. The company's market cap stands at $7.2 million.
  • Jaguar Health (NASDAQ:JAGX) stock increased by 6.48% to $0.78. The company's market cap stands at $4.0 million.
  • MAIA Biotechnology (AMEX:MAIA) shares moved upwards by 6.15% to $1.38. The market value of their outstanding shares is at $79.6 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares moved upwards by 5.15% to $6.93. The market value of their outstanding shares is at $2.7 million.
  • Jin Medical International (NASDAQ:ZJYL) shares rose 4.16% to $2.29. The market value of their outstanding shares is at $18.1 million.
  • Beyond Air (NASDAQ:XAIR) shares rose 4.09% to $3.81. The company's market cap stands at $3.9 million.

Losers

  • CollPlant Biotechnologies (NASDAQ:CLGN) stock fell 15.6% to $0.31 during Tuesday's after-market session. The market value of their outstanding shares is at $7.3 million.
  • CDT Equity (NASDAQ:CDT) stock decreased by 11.49% to $1.31. The company's market cap stands at $1.3 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares declined by 7.3% to $0.13. The company's market cap stands at $5.0 million.
  • USBC (AMEX:USBC) stock declined by 6.04% to $0.45. The company's market cap stands at $164.1 million.
  • Cadrenal Therapeutics (NASDAQ:CVKD) shares decreased by 5.97% to $1.42. The company's market cap stands at $6.2 million.
  • Inventiva (NASDAQ:IVA) shares decreased by 5.67% to $4.5. The company's market cap stands at $1.1 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.